Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medicine. A portfolio model of drug development for tuberculosis.

Literature DB >> 16513969

Medicine. A portfolio model of drug development for tuberculosis.

Seth W Glickman¹, Emma B Rasiel, Carol Dukes Hamilton, Arsen Kubataev, Kevin A Schulman.

Abstract

Entities: Disease

Mesh：

Substances：
Antitubercular Agents

Year: 2006 PMID： 16513969 DOI： 10.1126/science.1119299

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Synthesis and selection of de novo proteins that bind and impede cellular functions of an essential mycobacterial protein.

Authors: Alka Rao; Geeta Ram; Adesh Kumar Saini; Reena Vohra; Krishan Kumar; Yogendra Singh; Anand Ranganathan
Journal: Appl Environ Microbiol Date: 2006-12-22 Impact factor: 4.792

2. Planning to improve global health: the next decade of tuberculosis control.

Authors: Dermot Maher; Chris Dye; Katherine Floyd; Andrea Pantoja; Knut Lonnroth; Alasdair Reid; Eva Nathanson; Thad Pennas; Uli Fruth; Jane Cunningham; Heather Ignatius; Mario C Raviglione; Irene Koek; Marcos Espinal
Journal: Bull World Health Organ Date: 2007-05 Impact factor: 9.408

Review 3. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors: Christopher Dye
Journal: Nat Rev Microbiol Date: 2009-01 Impact factor: 60.633

Review 4. Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors: Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal: Expert Opin Pharmacother Date: 2009-02 Impact factor: 3.889

Review 5. New drugs and regimens for treatment of TB.

Authors: Eric Leibert; William N Rom
Journal: Expert Rev Anti Infect Ther Date: 2010-07 Impact factor: 5.091

Review 6. Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.

Authors: Rianna Stefanakis; Andrew S Robertson; Elizabeth L Ponder; Melinda Moree
Journal: PLoS Negl Trop Dis Date: 2012-10-25

Medicine. A portfolio model of drug development for tuberculosis.

1. Synthesis and selection of de novo proteins that bind and impede cellular functions of an essential mycobacterial protein.

2. Planning to improve global health: the next decade of tuberculosis control.

Review 3. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Review 4. Tuberculosis pharmacotherapy: strategies to optimize patient care.

Review 5. New drugs and regimens for treatment of TB.

Review 6. Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.

Review 7. New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline.

8. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.

9. Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

10. Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.